This finding is consistent with our results, further indicates that low expression of GPX2 may impair cellular capacity to scavenge reactive oxygen species (ROS), thereby resulting in the accumulation of oxidative stress and genomic damage, which ultimately facilitates tumor progression. The gene discussed is GPX2; the disease is neoplasm.